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Abstract
Introduction and hypothesis Patient decision aids (PDAs) facilitate shared decision making allowing patients to make decisions
about their healthcare that take into account their personal values and preferences. The aim of this study was to establish whether
a PDA used in women requiring stress incontinence surgery is helpful to women when making choices about the treatments they
choose by using a Decision Conflict Scale (DCS).
Methods Forty-five consecutive women were identified as having stress urinary incontinence and had completed all conservative
treatments. All patients included in the study had stress urinary incontinence confirmed on urodynamic testing and were given the
PDA at the point where they needed to make a decision about surgery. Following completion of the PDA, patients were given a
DCS to complete which measures personal perceptions of uncertainty when making a decision about treatment.
Results Forty-three out of 45 (95.5%) patients scored 4/4 for the DCS indicating they were sure of their decision. Two patients
(4.5%) scored 3/4 andwere therefore unsure of their choice. No patient scored < 3 on the DCS. The choice of procedures varied in
all the ages and two women opted to have no treatment.
Conclusions The use of a PDA in the surgical treatment of stress urinary incontinence reduces decision conflict and ensures
patients are sure of their decision, understand the information provided as well as the risk benefit ratio of the various options and
feel they have adequate support and advice to make a choice.
Keywords Patient decision aid . PDA . Stress incontinence surgery . Shared decisionmaking . Decision conflict
Introduction
The consent process is an exchange of information between
the doctor and patient which needs to be tailored to the indi-
vidual circumstances. However, it is important not to make
assumptions about the amount of information a patient may
want, the factors theymay consider significant and the level of
knowledge of the proposed treatment.
For consent to be fully informed it is advised that wherever
possible patients should be involved in the decision-making
process. In accordance with General Medical Council guid-
ance on Consent [1], doctors use their specialist knowledge
and expertise to identify which investigations and treatments
are likely to be of overall benefit. These options are then
explained to the patient whilst highlighting the potential ben-
efits, risks, burdens and side effects of each option. When
informing patients about the various treatments it is important
to inform them of any uncertainties including the likely suc-
cess and failure. It is also important to highlight the option of
no treatment. It is then the patient’s prerogative to weigh up
the different options and decide whether they wish to accept
any of the options or opt for no active treatment.
When sharing information with patients this should be
done in a manner that patients can understand. Patients should
be allowed an opportunity to reflect on the options before they
make a decision, particularly where the information is com-
plex and the treatment has considerable risks. This process of
shared decision making encourages active participation by
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patients in their healthcare decisions. This can be further fa-
cilitated by the use of patient decision aids (PDAs).
PDAs allow patients to make informed decisions about
healthcare choices taking into account their personal values
and preferences [2]. This can be for both diagnostic and ther-
apeutic procedures. They make it easier for patients and clini-
cians to discuss treatment options [3–5]. A PDA has the fol-
lowing objectives:
– Inform patients of the evidence base to the available
options;
– Enable patients to identify what is important to them so
that their choices reflect their preferences and values;
– Encourage active participation by the patient in the
decision-making process.
The aim of this study was to establish whether a PDA used
in women requiring stress incontinence surgery is helpful to
women when making choices about the treatments they
choose by using a Decision Conflict Scale.
Methods
This study was conducted in two units using a PDA devel-
oped for women scheduled to undergo stress incontinence
surgery. Data were collected over a 12-month period
(March 2018–February 2019). At both units where the au-
thors work, all patients were offered all four surgical
choices for stress urinary incontinence including bulking
agents, colposuspension, fascial slings and synthetic
midurethral tapes. Patient information leaflets developed
by IUGA (International Urogynaecology Association)
and BSUG (British Society of Urogynaecology) were used
and leaflets on all the procedures were provided to all the
patients when providing them with the PDA. The counsel-
ling in all cases was by the two authors. All patients agreed
to work through the PDA.
The development of the PDAwent through the usual pro-
cesses described for the development of these tools and both
patients and clinicians had input into this process. This includ-
ed the following steps:
(1) Scoping and design: The content was guided by a needs
analysis, scientific evidence and guidelines for the man-
agement of stress urinary incontinence.
(2) Alpha testing with patients and clinicians in an iterative
process: this involved testing the comprehensibility and
usability of the PDA by volunteers willing to participate.
(3) Beta testing in real-life conditions: the feasibility was
testing including by individuals who were not involved
in the design of the PDA.
The PDA was developed in accordance with the Ottawa
Decision Support Framework [6]. This is based on expectancy
value, decisional conflict and social support theories. This
framework includes three key components:
(1) assessment of determinants of decisions for both patients
and clinicians;
(2) provision of decision support interventions to prepare the
patient and clinician to make and implement a decision;
(3) evaluation of the success of the interventions at improv-
ing the quality and outcomes of the decision process.
Further details of the development of the PDAwill not be
discussed in this article. The PDA used for this study is avail-
able as Appendix 1.
For the purposes of this study, the utility of the PDA in
clinical practice was tested in the beta testing phase.
The tool used to assess the utility of the PDA in clinical
practice was the Decision Conflict Scale (DCS). DCS measures
personal perceptions of uncertainty when making a decision
about treatment. It takes into account the modifiable factors con-
tributing to uncertainty such as feeling uninformed or being un-
clear about personal values or even feeling unsupported in deci-
sion making. It also assesses feelings of whether the choice is
informed, values based and likely to be implemented to result in
satisfaction. The degree of decisional conflict can be reduced
with the use of decision support interventions such as the PDA.
There are significant data to support the effects of using a PDA
on decisional conflict [7].
There are four versions of the DCS [8]. One is recommend-
ed for use in clinical practice and the remaining three are
research tools. The version used for the purposes of this study
was the clinical version, also referred to as the BSURE^ test
version [9]. This has been validated for use in clinical practice.
This has four items and two response categories and is shown
in Table 1 with the responses obtained.
Items are scored as B1^ for Byes^ and B0^ for Bno^. Score
ranges can be from 0 indicating extremely high decisional con-
flict to 4 indicating no decisional conflict. A score ≤ 3 indicates
decisional conflict whereas a score of 4 indicates no decisional
conflict.
Table 1 Decision conflict scale
Response
(yes/no)
Sure of myself Do you feel SURE about the best
choice for you?
43/2
Understanding
information
Do you know the benefits and
risks of each option?
45/0
Risk benefit ratio Are you clear about which benefits
and risks matter to you most?
45/0
Encouragement Do you have enough support and
advice to make a choice?
45/0
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On this basis, assuming a one-point difference is of clinical
and practical importance, then to have an 80% power of de-
tecting a 1-point mean difference in the DCS at the 5% (two-
sided) level would require 35 patients.
The age and demographic data of the women completing the
studywere analysed. All women included in this study were able
to speak and understand English as their first language and had
completed conservative treatments for their stress urinary incon-
tinence. All women included in the study had urodynamic prov-
en stress urinary incontinence and were given the PDA to enable
them tomake an informed decision about their choice of surgery.
They were then invited back to the outpatient department to
inform the clinician of their decision. At this point they were
given the DCS to complete to see how beneficial the PDA had
been to their decision-making process.
A few months after the introduction of the PDA the IMMDR
(Independent Medicines and Medical Devices Review), referred
to as the Cumberlege Review, implemented a pause on the use of
vaginal mesh for incontinence in the UK [10]. Patients and cli-
nicians were not made aware of this pause beforehand.
Following the pause, though the synthetic tape option was no
longer available, it was still on the PDA. As part of this survey
we assessed whether women’s preferred choice of surgical pro-
cedure changed after the pause was implemented. All patients
were discussed at the local Urogynaecology MDT. For the cases
reported here, there was no conflict between the patient’s choice
of surgery and theMDTconsensus to their choice, but thesewere
all cases of primary incontinence surgery.
This was conducted as a service evaluation so formal eth-
ical approval was not required.
Results
Forty-five consecutive women were given the PDA prior to
stress urinary incontinence surgery. Themean age of the wom-
en was 48.27 (range 29–72 years) and all women were white
Caucasians who spoke English as their first language.
Forty-three out of 45 (95.5%) patients scored 4/4 for the
DCS and responded with a Byes^ to all four items. Two pa-
tients (4.5%) scored 3/4 and were unsure of their choice even
though they responded in the affirmative to the other items.
No patient scored < 3 on the DCS.
The choice of procedure made by patients is shown in
Table 2. Two patients opted for no surgical treatment after
receiving the PDA. Both these patients scored 4/4 on the
DCS indicating no decisional conflict, i.e., they were sure of
their decision not to have treatment.
Age seemed to have no bearing on the surgical procedure
women chose.
Before the implementation of the vaginal mesh pause 50%
(13/26) women opted for synthetic tapes, but after the pause
this was only 5%(1/19). This patient has opted to wait for
pause reversal rather than proceed with any of the other op-
tions. The rates of the different procedures before and after the
UK vaginal mesh pause are shown in Table 2. Both women
who opted for no treatment did so after the implementation of
the vaginal mesh pause.
Discussion
The use of a PDA in the surgical treatment of stress urinary
incontinence reduces decision conflict to a minimum by en-
suring patients are sure of their decision, understand the infor-
mation provided and the risk-benefit ratio of the various op-
tions as well as feeling they have adequate support and advice
to make a choice. Age does not impact on the surgical choice
women make. The implementation of a pause on the use of
synthetic mid-urethral tapes appears to have altered the pre-
ferred choice of surgical procedure for stress urinary inconti-
nence. However, as the pause coincides with recent adverse
publicity for the use of mesh, it is difficult to know whether
this reduction was partly attributable to this adverse media
attention. It is also possible that the counselling offered had
an impact on patient choice as clinicians were unable to per-
form the synthetic tape even if patients chose it.
This is the first study analysing the utility of a PDA in
clinical practice for stress urinary incontinence surgery using
a formal tool to assess conflict score. The DCS has shown
promise for screening for decisional conflict in both French-
and English-speaking patients. It has been validated for use
and shown to have both reliability and validity when used in
practice [9] and has been used in other studies to assess utility
of a PDA in practice.
This survey suggests that using a PDA is useful in ensuring
patients are certain about their choices when choosing SUI
surgery. This is encouraging for clinicians and has the poten-
tial to affect future practice in this area. As this survey only
reports on data after the implementation of the PDA, it is
difficult to be certain that there has been a positive impact
on decision making as there is no comparator either before
the introduction of the PDA or from analysis of a cohort of
patients who did not receive the PDA. The results can only be
extrapolated to white Caucasian English-speaking women as
the study cohort included this group.
Table 2 Choice of procedure
Procedure N (%) N before pause N after pause
Bulking agent 13 (29) 7 6
Colposuspension 10 (22) 2 8
Fascial sling 6 (13) 4 2
Synthetic tape 14 (31) 13 1
None 2 (4) NA NA
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In a study by Spyroulis et al. [11] using a PDA designed for
stress urinary incontinence surgery, it was proposed that there
was better patient understanding of their values and choices,
and patients felt better informed and better valued. Their study
cohort included 30 women and they did not test the utility of
the PDA using a formal tool. Their study analysed patient
values as derived from the PDA instead.
PDAs have been used across a wide range of conditions for
screening, diagnostics and therapy. In a Cochrane systematic
review [4] analysing the impact of PDAs on a wide range of
conditions, it was shown that they decreased decisional conflict
related to feeling uninformed (MD -9.28/100; 95% CI -12.20 to
−6.36; 27 studies; N = 5707; high-quality studies; N = 5068;
high-quality evidence), and the proportion of people who were
passive in decision making (RR 0.68; 95% CI 0.55 to 0.83; 16
studies; N = 3180; moderate-quality evidence). These were used
in a range of health treatment and screening decisions and were
found to reduce the proportion of undecided participants. PDAs
also appeared to have a positive effect on patient-clinician com-
munication. In addition exposure to a decision aid improved
satisfaction with their decision, the decision-making process
and/or the preparation for decision making compared with usual
care. This survey shows that in the context of SUI surgery, a
PDA has the same benefits as its use in other clinical scenarios.
Introducing PDA in practice has significant implications for
the clinical consultation, especially the duration [12]. In a
Cochrane systematic review [4] of PDA, a variable impact on
the length of the clinical consultation was shown, ranging from
reducing the consultation by 8 min to increasing it by 23 min
compared with a standard consultation (median + 2.5 min).
Over the past few years there have been significant concerns
about the safety of continence surgery. There have also been
many court actions and increasingly clinicians are being success-
fully sued for failing to inform patients adequately of all options
prior to surgery. TheMontgomery [13] ruling of 2015 drew fresh
attention to informed consent. The use of a PDA ensures that the
consent process is Montgomery compliant and that all material
risks to which a reasonable person would attach significance
have been discussed. This survey also lends credence to the
hypothesis that the use of a PDA allows a patient to be sure of
their decision and therefore take responsibility for the choices.
It is unclear whether clinicians’ personal preferences impact
the choices patients make following use of the PDA. In addition,
if a clinician is unable to offer all the choices for surgery, it is
unclear whether a patient’s decision making would be influenced
by this. The impact of the pause has been a proxy for this situa-
tion and indicates that where all options are not available, patients
choose alternatives. Further research is needed to investigate
these areas of uncertainty.
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